Envista (NVST)
(Delayed Data from NYSE)
$19.00 USD
-0.81 (-4.09%)
Updated May 3, 2024 04:00 PM ET
After-Market: $19.01 +0.01 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 40% (151 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.83 | 1.69 | 9.99 |
Current Quarter Estimate | 0.31 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 0.43 | 4.88 | 52.54 |
Next Quarter Estimate | 0.32 | 7.06 | 61.00 |
Next Year Estimate | 1.42 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -17.65 | 18.40 | 15.67 |
Next Year | 12.70 | 24.30 | 9.31 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | 1.00 | 10.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 13.48 | -13.85 |
Price/Book (MRQ) | 0.79 | 1.90 |
Price/Cash Flow (MRFY) | 7.46 | 10.67 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -4.70% | 12.53% |
Return on Equity (TTM) | 5.84% | 13.71% |
Debt to Equity (MRQ) | 0.34 | 19.86 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.